Cited by 951Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementCardiovascular and Diving-Related Complications

The DOI matches its Crossref record, with a small difference in title or year; 27 of the 28 references it cites were found in a registry or an index.

Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke: Results From a Population-Based Study

Marini, Carmine, De Santis, Federica, Sacco, Simona, Russo, Tommasina, Olivieri, Luigi, Totaro, Rocco, Carolei, Antonio·2005·Stroke

DOI 10.1161/01.str.0000166053.83476.4a

Open this paper in CoChat — free account

Abstract

Background and Purpose— Atrial fibrillation (AF) is a major risk factor for ischemic stroke and its prevalence increases steeply with age. Population-based data on its influence on stroke outcome are scarce. Methods— We evaluated the prevalence of AF and its influence on prognosis in patients with a first-ever ischemic stroke from a population-based registry. Results— The presence of AF at stroke onset and during the acute phase was confirmed by a standard electrocardiogram in 869 (24.6%) of 3530 patients with ischemic stroke. With respect to patients without the arrhythmia, those with AF were more frequently women, aged 80 years and older, with coronary heart disease and peripheral arterial disease. The presence of AF was associated with high 30-day (32.5%; 95% CI, 29.3 to 35.6) and 1-year case-fatality rates (49.5%; 95% CI, 46.2 to 52.8), with a higher stroke recurrence rate within the first year of follow-up (6.6% versus 4.4%; P =0.046) and with the worst survival after an average follow-up of 45.2 months ( P <0.0001). At the multivariate Cox regression analysis, AF was an independent predictor of 30-day and 1-year mortality. Approximately 17% of all deaths were attributable to the presence of AF. Conclusions— We found a high prevalence of AF in patients with a first-ever ischemic stroke, especially among elderly women. The overall contribution of AF to stroke mortality was relevant, suggesting that together with new strategies to prevent the development of the arrhythmia more appropriate treatments are needed, mostly in elderly women.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.str.0000166053.83476.4a

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Classification and natural history of clinically identifiable subtypes of cerebral infarction
Bamford, J., Sandercock, P., Dennis, M., Warlow, C., & Burn, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)93206-o · Cited by 3,294
Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century
Feigin, V. L., Lawes, C. M., Bennett, D. A., & Anderson, C. S. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00266-7 · Cited by 1,932
Stroke Severity in Atrial Fibrillation
Lin, H., Wolf, P. A., Kelly‐Hayes, M., Beiser, A., Kase, C. S., Benjamin, E. J., & D’Agostino, R. B. (1996) · Stroke · doi:10.1161/01.str.27.10.1760 · Cited by 1,412
Cerebrovascular disease in the community: results of a WHO collaborative study.
Aho, K., Harmsen, P., Hatano, S., Marquardsen, J., Smirnov, V. E., & Strasser, T. (1980) · Europe PMC (PubMed Central) · Cited by 1,284
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
Hart, R. G., Pearce, L. A., Rothbart, R. M., McAnulty, J. H., ASINGER, R. W., & Halperin, J. L. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00489-1 · Cited by 662
Acc/aha/esc guidelines for the management of patients with atrialfibrillation: executive summary a report of the american college ofcardiology/american heart association task force on practice guideli
Fúster, & Westerling, R. (2001) · Circulation · Cited by 607
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Circulation · doi:10.1161/circ.104.17.2118 · Cited by 607

Show all 28 references

Research works printed but not linked: 8

10.1161/str.22.8.1866765 · DOI
10.1161/str.32.3.803 · DOI
10.1161/str.28.12.2500 · DOI
10.1161/circ.99.23.3028 · DOI
10.1161/str.32.10.2333 · DOI
10.1161/str.31.12.2925 · DOI
10.1161/str.28.2.311 · DOI
10.1161/str.27.10.1760 · DOI

Sorted by citations

Items 101–200 of 951

Performance of the CHARGE-AF risk model for incident atrial fibrillation in the EPIC Norfolk cohort
Pfister, R., Brägelmann, J., Michels, G., Wareham, N. J., Luben, R., & Khaw, K. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314544045 · Cited by 65
Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis—data from the German Competence Network on Atrial Fibrillation
von Eisenhart Rothe, A., Hutt, F., Baumert, J., Breithardt, G., Goette, A., Kirchhof, P., & Ladwig, K.-H. (2015) · Europace · doi:10.1093/europace/euv018 · Cited by 63
Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
Rognoni, C., Marchetti, M., Quaglini, S., & Liberato, N. L. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-013-0144-3 · Cited by 64
Vitamin K Antagonist Treatment in Patients With Atrial Fibrillation and Time in Therapeutic Range in Four European Countries
Cotté, F.-E., Benhaddi, H., Duprat-Lomon, I., Doble, A., Marchant, N., Letierce, A., & Huguet, M. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.07.016 · Cited by 66
A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
Obamiro, K. O., Chalmers, L., & Bereznicki, L. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0171-6 · Cited by 63
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Slot, K. B., & Berge, E. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008980.pub3 · Cited by 68
Sex Differences in Short-Term Outcomes After Acute Ischemic Stroke
Irie, F., Kamouchi, M., Hata, J., Matsuo, R., Wakisaka, Y., Kuroda, J., Ago, T., Kitazono, T., Ishitsuka, T., Fujimoto, S., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.006739 · Cited by 61
Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices
Chen, W., Khurshid, S. S., Singer, D. E., Atlas, S. J., Ashburner, J. M., Ellinor, P. T., McManus, D. D., Lubitz, S. A., & Chhatwal, J. (2022) · JAMA Health Forum · doi:10.1001/jamahealthforum.2022.2419 · Cited by 61
Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban
Tepper, P. G., Mardekian, J., Masseria, C., Phatak, H. M., Kamble, S., Abdulsattar, Y., Petkun, W., & Lip, G. Y. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205989 · Cited by 60
The role of haematological traits in risk of ischaemic stroke and its subtypes
Harshfield, E. L., Sims, M. C., Traylor, M., Ouwehand, W. H., & Markus, H. S. (2019) · Brain · doi:10.1093/brain/awz362 · Cited by 64
Atrial fibrillation detection using convolutional neural networks on 2-dimensional representation of ECG signal
Król-Józaga, B. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.103470 · Cited by 60
Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care
Johnson, M. E., Lefèvre, C., Collings, S., Evans, D., Kloss, S., Ridha, E., & Maguire, A. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011471 · Cited by 59
Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation
Sur, N. B., Wang, K., Tullio, M. R. D., Gutierrez, C. M., Dong, C., Koch, S., Gardener, H. E., García-Rivera, E. J., Zevallos, J. C., Burgin, W. S., et al. (2019) · Stroke · doi:10.1161/strokeaha.118.023959 · Cited by 60
Atrial Fibrillation
Camm, A. J., Savelieva, I., Ho, S. Y., Lindsay, B. D., Nattel, S., & Shinagawa, K. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00044-2 · Cited by 60
Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trial
Steinhubl, S. R., Mehta, R. R., Ebner, G. S., Ballesteros, M. M., Waalen, J., Steinberg, G., Crocker, P. V., Felicione, E., Carter, C. T., Edmonds, S., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.02.011 · Cited by 59
Cardiac Workup of Ischemic Stroke
Ustrell, X., & Pellisé, A. (2010) · Current Cardiology Reviews · doi:10.2174/157340310791658721 · Cited by 59
Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study
Fauchier, L., Samson, A., Chaize, G., Gaudin, A.-F., Vainchtock, A., Bailly, C., & Cotté, F.-E. (2015) · Open Heart · doi:10.1136/openhrt-2015-000290 · Cited by 58
A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke
Levin, L.-A., Husberg, M., Sobocinski, P. D., Kull, V. F., Friberg, L., Rosenqvist, M., & Davidson, T. (2015) · Europace · doi:10.1093/europace/euu213 · Cited by 56
Incidence of Atrial Fibrillation in Relation to Changing Heart Rate Over Time in Hypertensive Patients
Okin, P. M., Wachtell, K., Kjeldsen, S. E., Julius, S., Lindholm, L. H., Dahlöf, B., Hille, D. A., Nieminen, M. S., Edelman, J. M., & Devereux, R. B. (2008) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.795351 · Cited by 57
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada
Sharma, M., Bradley-Kennedy, C., Clemens, A., Monz, B. U., Peng, S., Roskell, N., Sorensen, S. V., & Kansal, A. R. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0388 · Cited by 56
Atrial fibrillation in patients with ischemic stroke: A population-based study
Thygesen, S. K., Johnsen, S. P., Frost, L., & Eagle (2009) · Clinical Epidemiology · doi:10.2147/clep.s4794 · Cited by 56
Atrial Fibrillation and Race – A Contemporary Review
Amponsah, M., Benjamin, E. J., & Magnani, J. W. (2013) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-013-0327-8 · Cited by 55
Smartwatch-based detection of cardiac arrhythmias: Beyond the differentiation between sinus rhythm and atrial fibrillation
Strik, M., Ploux, S., Ramirez, F. D., Abu-Alrub, S., Jaı̈s, P., Haı̈ssaguerre, M., & Bordachar, P. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.06.1176 · Cited by 56
Feasibility of a T-Shirt-Type Wearable Electrocardiography Monitor for Detection of Covert Atrial Fibrillation in Young Healthy Adults
Fukuma, N., Hasumi, E., Fujiu, K., Waki, K., Toyooka, T., Komuro, I., & Ohe, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-48267-1 · Cited by 53
Barriers to Anticoagulation in Patients With Atrial Fibrillation
Lane, D. A., & Lip, G. Y. H. (2007) · Stroke · doi:10.1161/strokeaha.107.496554 · Cited by 53
N-Terminal Pro-Brain Natriuretic Peptide Shows Diagnostic Accuracy for Detecting Atrial Fibrillation in Cryptogenic Stroke Patients
Fonseca, A. C., Brito, D. A., Melo, T. P. E., Geraldes, R., Canhão, P., Caplan, L. R., & Ferro, J. M. (2013) · International Journal of Stroke · doi:10.1111/ijs.12126 · Cited by 52
A Score for Predicting Paroxysmal Atrial Fibrillation in Acute Stroke Patients: iPAB Score
Yoshioka, K., Watanabe, K., Zeniya, S., Ito, Y., Hizume, M., Kanazawa, T., Tomita, M., Ishibashi, S., Miake, H., Tanaka, H., et al. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.06.019 · Cited by 51
Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities
Dobesh, P. P., & Fanikos, J. R. (2015) · Drugs · doi:10.1007/s40265-015-0452-4 · Cited by 50
Serum Uric Acid and Risk of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation
Tang, R., Dong, J., Yan, X., Du, X., Kang, J.-P., Wu, J., Yu, R., Long, D., Ning, M., Sang, C., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.06.009 · Cited by 50
Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk
Potpara, T., & Lip, G. Y. H. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.07.003 · Cited by 52
Detecting undiagnosed atrial fibrillation in UK primary care: Validation of a machine learning prediction algorithm in a retrospective cohort study
Sekelj, S., Sandler, B. C., Johnston, E., Pollock, K. G., Hill, N. R., Gordon, J. P., Tsang, C., Khan, S. N., Ng, F. S., & Farooqui, U. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320942338 · Cited by 50
Time Trends in Atrial Fibrillation-Associated Stroke and Premorbid Anticoagulation
Yiin, G. S. C., Li, L., Béjot, Y., & Rothwell, P. M. (2018) · Stroke · doi:10.1161/strokeaha.118.022249 · Cited by 50
Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source during 3 Years of Prolonged Monitoring with an Implantable Loop Recorder
Rogalewski, A., Kitsiou, A., Kalyani, M., Deelawar, S., Tribunyan, S., Greeve, I., Minnerup, J., Israel, C. W., & Schäbitz, W. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1346-2899 · Cited by 50
Prevalence and incidence of non-arteritic anterior ischaemic optic neuropathy in South Korea: a nationwide population-based study
Lee, J.-Y., Park, K.-A., & Oh, S. Y. (2018) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2017-311140 · Cited by 53
Epidemiology of Stroke in Italy
Sacco, S., Stracci, F., Cerone, D., Ricci, S., & Carolei, A. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00594.x · Cited by 49
Self-citation
A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care
Filippi, A., Alacqua, M., Cowell, W., Shakespeare, A., Mantovani, L. G., Bianchi, C., Cricelli, C. A., & Mazzaglia, G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-08-0525 · Cited by 49
The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines
Pisters, R., van Oostenbrugge, R. J., Knottnerus, I. L. H., de Vos, C. B., Boreas, A., Lodder, J., Prins, M. H., Crijns, H. J. G. M., & Tieleman, R. G. (2010) · EP Europace · doi:10.1093/europace/euq080 · Cited by 49
Incidence and predictors of atrial fibrillation episodes as detected by implantable loop recorder in patients at risk: From the LOOP study
Diederichsen, S. Z., Haugan, K., Brandes, A., Graff, C., Krieger, D. W., Kronborg, C., Holst, A. G., Nielsen, J. B., Køber, L., Højberg, S., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.09.009 · Cited by 49
Deep learning of left atrial structure and function provides link to atrial fibrillation risk
Pirruccello, J. P., Achille, P. D., Choi, S. H., Rämö, J. T., Khurshid, S. S., Nekoui, M., Jurgens, S. J., Nauffal, V., Kany, S., FinnGen, et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48229-w · Cited by 52
High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme
Sandhu, R. K., Dolovich, L. R., Deif, B., Barake, W. M., Agarwal, G., Grinvalds, A., Lim, T., Quinn, F. R., Gladstone, D. J., Conen, D., et al. (2016) · Open Heart · doi:10.1136/openhrt-2016-000515 · Cited by 48
Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation
Hellwig, S., Grittner, U., Audebert, H. J., Endres, M., & Hæusler, K. G. (2017) · EP Europace · doi:10.1093/europace/eux087 · Cited by 47
Detection of Atrial Fibrillation in Cryptogenic Stroke
Hæusler, K. G., Tütüncü, S., & Schnabel, R. B. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0871-1 · Cited by 49
Assessment of atrial fibrillation patients' education needs from patient and clinician perspectives: A qualitative descriptive study
Salmasi, S., Kwan, L., MacGillivray, J., Bansback, N. J., Vera, M. A. D., Barry, A. R., Harrison, M. J., Andrade, J. G., Lynd, L. D., & Loewen, P. S. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.11.015 · Cited by 47
Stroke and Obstructive Sleep Apnea: A Review
Barone, D. A., & Krieger, A. C. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0334-8 · Cited by 48
Non-steroidal anti-inflammatory drugs and the risk of atrial fibrillation: a population-based follow-up study
Krijthe, B. P., Heeringa, J., Albert Hofman, D., Franco, O. H., & Stricker, B. H. C. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004059 · Cited by 47
Unrecognized myocardial infarction and risk of atrial fibrillation: The Rotterdam Study
Krijthe, B. P., Leening, M. J. G., Heeringa, J., Kors, J. A., Albert Hofman, D., Franco, O. H., Witteman, J. C. M., & Stricker, B. H. C. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.057 · Cited by 45
Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting
Kleintjens, J., Li, X., Simoens, S., Thijs, V., Goethals, M., Rietzschel, E. R., Asukai, Y., Saka, Ö. R., Evers, T., Faes, P., et al. (2013) · PharmacoEconomics · doi:10.1007/s40273-013-0087-9 · Cited by 44
Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study
Krittayaphong, R., Rangsin, R., Thinkhamrop, B., Hurst, C. P., Rattanamongkolgul, S., Sripaiboonkij, N., & Yindeengam, A. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0232-4 · Cited by 42
Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation ― SAMURAI-NVAF Study ―
Yoshimura, S., Koga, M., Sato, S., Todo, K., Yamagami, H., Kumamoto, M., Itabashi, R., Terasaki, T., Kimura, K., Yagita, Y., et al. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0067 · Cited by 43
Effect of Statin Therapy on Outcomes of Patients With Acute Ischemic Stroke and Atrial Fibrillation
Choi, K., Seo, W., Park, M., Kim, J., Chung, J., Bang, O. Y., Kim, G., Song, T., Kim, B. J., Heo, S. H., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013941 · Cited by 43
Clinical frailty is independently associated with non‐prescription of anticoagulants in older patients with atrial fibrillation
Induruwa, I., Evans, N. R., Aziz, A., Reddy, S. M., Khadjooi, K., & Romero‐Ortuño, R. (2017) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13058 · Cited by 42
Multivariate Correlation Measures Reveal Structure and Strength of Brain–Body Physiological Networks at Rest and During Mental Stress
Pernice, R., Antonacci, Y., Zanetti, M., Busacca, A., Marinazzo, D., Faes, L., & Nollo, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.602584 · Cited by 43
New anticoagulant treatments to protect against stroke in atrial fibrillation
Potpara, T., Lip, G. Y. H., & Apostolakis, S. Z. (2012) · Heart · doi:10.1136/heartjnl-2012-301841 · Cited by 41
Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study
Anjum, M., Ariansen, I., Hjellvik, V., Selmer, R. M., Kjerpeseth, L. J., Skovlund, E., Myrstad, M., Ellekjær, H., Christophersen, I. E., Tveit, A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad659 · Cited by 41
Renal denervation: effects on atrial electrophysiology and arrhythmias
Linz, D., van Hunnik, A., Ukena, C., Ewen, S., Mahfoud, F., Schirmer, S. H., Lenski, M., Neuberger, H., Schotten, U., & Böhm, M. (2014) · Clinical Research in Cardiology · doi:10.1007/s00392-014-0695-1 · Cited by 41
Incidence and Cost of Stroke and Hemorrhage in Patients Diagnosed with Atrial Fibrillation in France
Cotté, F.-E., Chaize, G., Kachaner, I., Gaudin, A.-F., Vainchtock, A., & Durand‐Zaleski, I. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.08.022 · Cited by 41
A Structured Reading Algorithm Improves Telemetric Detection of Atrial Fibrillation After Acute Ischemic Stroke
Kallmünzer, B., Breuer, L., Hering, C., Raaz‐Schrauder, D., Kollmar, R., Huttner, H. B., Schwab, S., & Köhrmann, M. (2012) · Stroke · doi:10.1161/strokeaha.111.642199 · Cited by 41
Hospital Costs Associated With Atrial Fibrillation for Patients With Ischemic Stroke Aged 18–64 Years in the United States
Wang, G., Joo, H., Tong, X., & George, M. G. (2015) · Stroke · doi:10.1161/strokeaha.114.008563 · Cited by 41
Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications
Kim, J. H., Shah, P. M., Tantry, U. S., & Gurbel, P. A. (2016) · Current Heart Failure Reports · doi:10.1007/s11897-016-0308-6 · Cited by 41
A Systemic Review of the Integral Role of TRPM2 in Ischemic Stroke: From Upstream Risk Factors to Ultimate Neuronal Death
Zong, P., Lin, Q., Feng, J., & Yue, L. (2022) · Cells · doi:10.3390/cells11030491 · Cited by 42
Four-year trends in oral anticoagulant use and declining rates of ischemic stroke among 194,030 atrial fibrillation patients drawn from a sample of 12 million people
Maggioni, A. P., Dondi, L., Andreotti, F., Pedrini, A., Calabria, S., Ronconi, G., Piccinni, C. P., & Martini, N. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.10.017 · Cited by 41
Stroke and rheumatic heart disease: A systematic review of observational studies
Wang, D., Liu, M., Lin, S., Hao, Z., Tao, W., Chen, X., Luan, R., & Dong, W. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.06.017 · Cited by 40
Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms
Lubitz, S. A., Parsons, O., Anderson, C. D., Benjamin, E. J., Malik, R., Weng, L.-C. C., Dichgans, M., Sudlow, C. L. M., Rothwell, P. M., Rosand, J. M., et al. (2017) · Stroke · doi:10.1161/strokeaha.116.016198 · Cited by 39
Long-term risk of atrial fibrillation after the death of a partner
Graff, S., Fenger‐Grøn, M., Christensen, B., Pedersen, H., Christensen, J., Li, J., & Vestergaard, M. (2016) · Open Heart · doi:10.1136/openhrt-2015-000367 · Cited by 39
Atrial Fibrillation and Cause‐Specific Risks of Pulmonary Embolism and Ischemic Stroke
Hald, E. M., Rinde, L. B., Løchen, M., Mathiesen, E. B., Wilsgaard, T., Njølstad, I., Brækkan, S. K., & Hansen, J. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.006502 · Cited by 41
Comparison of the Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation in a UK Setting
Zheng, Y., Sorensen, S. V., Gonschior, A. K., Noack, H., Heinrich-Nols, J., Sunderland, T., & Kansal, A. R. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.09.015 · Cited by 40
Acute Hospital, Community, and Indirect Costs of Stroke Associated With Atrial Fibrillation
Hannon, N., Daly, L., Murphy, S., Smith, S., Hayden, D., Chróinín, D. N., Callaly, E. L., Horgan, G., Sheehan, O. C., Honari, B., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.005960 · Cited by 38
Clinical and Imaging Characteristics of Cerebral Infarction in Patients with Nonvalvular Atrial Fibrillation Combined with Cerebral Artery Stenosis
Sun, W., Li, G., Zeng, X., Lai, Z., Wang, M., Ouyang, Y., Zeng, G., Peng, J., Zhong, J., Xiao, D., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.43240 · Cited by 38
Predicting Ischemic Stroke in Patients with Atrial Fibrillation Using Machine Learning
Jung, S., Lee, E., Lee, E.-J., Bae, S., Kim, Y.-Y., Lee, D., Song, M.-K., & Yoo, S. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2703080 · Cited by 39
New Oral Anticoagulants in Elderly Patients with Atrial Fibrillation
DEEDWANIA, P. C. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.10.012 · Cited by 35
The burden of atrial fibrillation in the Netherlands
Heemstra, H. E., Nieuwlaat, R., Meijboom, M., & Crijns, H. J. G. M. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-011-0175-4 · Cited by 37
Improved Late Survival and Disability After Stroke With Therapeutic Anticoagulation for Atrial Fibrillation
Hannon, N., Callaly, E. L., Moore, A. R., Chróinín, D. N., Sheehan, O. C., Marnane, M., Merwick, Á., Kyne, L., Duggan, J., McCormack, P. M. E., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.602235 · Cited by 37
The Long-Term Use of Warfarin Among Atrial Fibrillation Patients Discharged From an Emergency Department With a Warfarin Prescription
Atzema, C. L., Austin, P. C., Chong, A. S., Dorian, P., & Jackevicius, C. A. (2015) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2015.03.024 · Cited by 37
Stroke Prevention With Oral Anticoagulation Therapy in Patients With Atrial Fibrillation
Lip, G. Y. H., & Lane, D. A. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0465 · Cited by 37
Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation
Heine, G. H., Brandenburg, V. M., & Schirmer, S. H. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0287 · Cited by 37
The Impact of New and Emerging Clinical Data on Treatment Strategies for Atrial Fibrillation
Prystowsky, E. N., Camm, A. J., Lip, G. Y. H., Allessie, M. A., Bergmann, J., BREITHARDT, G. E., Brugada, J., Crijns, H. J. G. M., Ellinor, P. T., Mark, D. B., et al. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01770.x · Cited by 37
The Influence of Stroke Risk Factors and Comorbidities on Assessment of Stroke Therapies in Humans and Animals
Ankolekar, S., Rewell, S. S. J., Howells, D. W., & Bath, P. M. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00802.x · Cited by 39
Novel oral anticoagulants in non-valvular atrial fibrillation
Potpara, T., & Lip, G. Y. H. (2013) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2013.07.008 · Cited by 36
N-Terminal Probrain Natriuretic Peptide as a Biomarker of Cardioembolic Stroke
Fonseca, A. C., Matias, J. S., Melo, T. P. E., Falcão, F., Canhão, P., & Ferro, J. M. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00606.x · Cited by 35
A deep neural network for 12-lead electrocardiogram interpretation outperforms a conventional algorithm, and its physician overread, in the diagnosis of atrial fibrillation
Smith, S. W., Rapin, J., Li, J., Fleureau, Y., Fennell, W. H., Walsh, B. M., Rosier, A., Fiorina, L., & Gardella, C. (2019) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2019.100423 · Cited by 39
ESC Working Group on e-Cardiology Position Paper: accuracy and reliability of electrocardiogram monitoring in the detection of atrial fibrillation in cryptogenic stroke patients
Dilaveris, P., Antoniou, C. K., Caiani, E. G., Casado-Arroyo, R., Climent, A. M., Cluitmans, M. J. M., Cowie, M., Doehner, W., Guerra, F., Jensen, M. T., et al. (2022) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztac026 · Cited by 40
A rapid access cardiology service for chest pain, heart failure and arrhythmias accurately diagnoses cardiac disease and identifies patients at high risk: a prospective cohort study
Tenkorang, J., Fox, K. F., Collier, T. J., & Wood, D. A. (2005) · Heart · doi:10.1136/hrt.2005.079376 · Cited by 36
Artificial-intelligence-based risk prediction and mechanism discovery for atrial fibrillation using heart beat-to-beat intervals
Lin, F., Zhang, P., Chen, Y., Liu, Y., Li, D., Tan, L., Wang, Y., Wang, D. W., Yang, X., Ma, F., et al. (2024) · Med · doi:10.1016/j.medj.2024.02.006 · Cited by 37
Short-term associations between ambient air pollution and acute atrial fibrillation episodes
Dahlquist, M., Frykman, V., Kemp-Gudmundsdottir, K., Svennberg, E., Wellenius, G. A., & Ljungman, P. L. S. (2020) · Environment International · doi:10.1016/j.envint.2020.105765 · Cited by 35
Ischemic Stroke and Heart Failure: Facts and Numbers. An Update
Barkhudaryan, A., Doehner, W., & Scherbakov, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051146 · Cited by 39
Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts
Xu, Y., Shoamanesh, A., Schulman, S., Dowlatshahi, D. D., Salman, R. A., Moldovan, I. D., Wells, P. S., & Alkherayf, F. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191137 · Cited by 35
Brain MRI to personalise atrial fibrillation therapy: current evidence and perspectives
Hæusler, K. G., Wilson, D., Fiebach, J. B., Kirchhof, P. F., & Werring, D. J. (2014) · Heart · doi:10.1136/heartjnl-2013-305151 · Cited by 36
Cause of death in spontaneous intracerebral hemorrhage survivors
Kuohn, L. R., Leasure, A. C., Acosta, J., Vanent, K. N., Murthy, S. B., Kamel, H., Matouk, C. C., Sansing, L. H., Falcone, G. J., & Sheth, K. N. (2020) · Neurology · doi:10.1212/wnl.0000000000010736 · Cited by 34
Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: The value of p wave dispersion in predicting arrhythmia occurrence
Marks, D., Ho, R., Then, R. K., Weinstock, J. L., Teklemariam, E., Kakadia, B., Collins, J. A., Andriulli, J. A., Hunter, K. M., Ortman, M. L., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.11.019 · Cited by 34
Impact of Anticoagulation before Stroke on Stroke Severity and Long-Term Survival
Hæusler, K. G., Konieczny, M., Endres, M., Villringer, A., & Heuschmann, P. U. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00672.x · Cited by 33
Using Dabigatran in Patients With Stroke
Alberts, M. J., Bernstein, R. A., Naccarelli, G. V., & Garcia, D. A. (2011) · Stroke · doi:10.1161/strokeaha.111.622498 · Cited by 34
Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial
Uittenbogaart, S. B., Gurp, N. V.-V., Erkens, P. M. G., Lucassen, W. A. M., Knottnerus, J. A., Winkens, B., van Weert, H. C. P. M., & Stoffers, J. (2015) · Trials · doi:10.1186/s13063-015-1006-5 · Cited by 33
Cryptogenic ischemic stroke and prevalence of asymptomatic atrial fibrillation
Jorfida, M., Antolini, M., Cerrato, E., Caprioli, M., Castagno, D., Garrone, P., Budano, C., Cerrato, P., & Gaïta, F. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000181 · Cited by 36
Atrial Fibrillation in Transient Ischemic Attack Versus Ischemic Stroke
Buchwald, F., Norrving, B. G., & Petersson, J. (2016) · Stroke · doi:10.1161/strokeaha.116.013988 · Cited by 33
Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review
Hsu, J. C., & Freeman, J. V. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1024 · Cited by 32
Predictors of Mortality Following Acute Stroke: A Cohort Study with 12 Years of Follow-Up
Rønning, O. M., & Stavem, K. (2010) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2010.09.012 · Cited by 33
Risk Factors for Poor Outcome and Mortality at 3 Months after the Ischemic Stroke in Patients with Atrial Fibrillation
Li, S., Zhao, X., Wang, C., Liu, L., Liu, G., Wang, Y., Wang, C., Jing, J., & Wang, Y.-J. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.04.025 · Cited by 32
Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group
Pharithi, R. B., Ranganathan, D., O’Brien, J., Egom, E. E. A., Burke, C., Ryan, D., McAuliffe, C. E., Vaughan, M., Coughlan, T., Morrissey, E., et al. (2018) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-018-1837-7 · Cited by 32
Identification of paroxysmal atrial fibrillation subtypes in over 13,000 individuals
Wineinger, N. E., Barrett, P. M., Zhang, Y., Irfanullah, I., Muse, E. D., Steinhubl, S. R., & Topol, E. J. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.08.012 · Cited by 32
Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation
Atzema, C. L., Jackevicius, C. A., Chong, A. S., Dorian, P., Ivers, N. M., Parkash, R., & Austin, P. C. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.190747 · Cited by 32

Authors: Marini, C., De Santis, F., Sacco, S., Russo, T., Olivieri, L., Totaro, R., & Carolei, A.
Affiliations: University of L'Aquila (IT)
From Clinica Neurologica, Università degli Studi di L’Aquila, L’Aquila, Italy.
ORCID: Sacco, Simona
Olivieri, Luigi
Totaro, Rocco
Carolei, Antonio
Venue: Stroke
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2005-06
Volume: 36
Issue: 6
Pages: 1115-1119
ISSN: 0039-2499 (ISSN-L)
1524-4628
DOI: 10.1161/01.str.0000166053.83476.4a
OpenAlex: W2055586130
Cited by: 949
References: 28
Citations by year: 2026: 32 · 2025: 41 · 2024: 49 · 2023: 42 · 2022: 62 · 2021: 52 · 2020: 47 · 2019: 61 · 2018: 60 · 2017: 59 · 2016: 49 · 2015: 66 · 2014: 63 · 2013: 68 · 2012: 59
FWCI: 9.82
Type: journal article
Language: en
Open access: closed
Locations: Stroke (publishedVersion)
PubMed (publishedVersion)
Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
Keywords: atrial fibrillation, ischemic stroke, stroke mortality, case fatality, stroke recurrence, stroke prognosis, older women, atrial fibrillation prevalence, cardiovascular risk factors, coronary artery disease, peripheral arterial disease
MeSH terms: Adult, Aged, Aged, 80 and over, Atrial Fibrillation, Electrocardiography, Female, Humans, Ischemia, Male, Middle Aged, Prognosis, Recurrence, Registries, Regression Analysis, Risk Factors, Time Factors, Incidence, Proportional Hazards Models, Treatment Outcome, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke: Results From a Population-Based Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks